544 results on '"Kalnicki, Shalom"'
Search Results
52. Characterizing the effects of radiation dermatitis on quality of life: A prospective survey-based study
53. A New Approach to Reduce Number of Split Fields in Large Field IMRT
54. Adaptive Planning in Intensity-Modulated Radiation Therapy for Head and Neck Cancers: Single-Institution Experience and Clinical Implications
55. 104: Financial Toxicity is Associated with Hospitalization During Concurrent Radiation and Chemotherapy
56. Breast cancer survivorship care during the COVID-19 pandemic within an urban New York Hospital System
57. 27409 Tissue ulceration and necrosis secondary to extravasation of mitomycin chemotherapy
58. Mitomycin extravasation injury: A case series
59. Change in Seroma Volume During Whole-Breast Radiation Therapy
60. Obtaining Normal Tissue Constraints Using Intensity Modulated Radiotherapy (IMRT) in Patients with Oral Cavity, Oropharnygeal, and Laryngeal Carcinoma
61. Additional file 1 of Individualized quality of life benefit and cost-effectiveness estimates of proton therapy for patients with oropharyngeal cancer
62. GSOR09 Presentation Time: 12:40 PM: FEBE: The Female Brachytherapy Experience. Assessing PTSD Symptom Rates in Women Treated for Locally Advanced Cervical Cancer with HDR Brachytherapy
63. Multi-scale Regularization Approaches of Non-parametric Deformable Registrations
64. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: Correlation and comparison with published Vienna applicator data
65. ICRU reference dose in an era of intensity-modulated radiation therapy clinical trials: Correlation with planning target volume mean dose and suitability for intensity-modulated radiation therapy dose prescription
66. Tumor Biology-Guided Radiotherapy Treatment Planning: Gross Tumor Volume Versus Functional Tumor Volume
67. Evidence-based practice of stereotactic radiosurgery: Outcomes from an educational course for neurosurgery and radiation oncology residents
68. Intensity modulated radiation therapy (IMRT) reduces the dose to the contralateral breast when compared to conventional tangential fields for primary breast irradiation
69. Hybrid tandem and ovoids brachytherapy in locally advanced cervical cancer: impact of dose and tumor volume metrics on outcomes
70. Association of Addition of Ablative Therapy Following Transarterial Chemoembolization With Survival Rates in Patients With Hepatocellular Carcinoma
71. Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York
72. Predictors of prostate bed recurrence on magnetic resonance imaging in patients with rising prostate-specific antigen after radical prostatectomy
73. Reply to Chowdhary et al
74. Extent of Prior Lung Irradiation and Mortality in COVID-19 Patients With a Cancer History
75. Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System
76. FLT3 ligand (CDX-301) and stereotactic radiotherapy for advanced non-small cell lung cancer.
77. Referral practices to dermatologists for the treatment of radiation dermatitis in the USA: a call for a multidisciplinary approach
78. Survival and toxicity differences between 5-day and weekly cisplatin in patients with locally advanced cervical cancer
79. Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: A brief technical report
80. CyberKnife Frameless Stereotactic Radiosurgery for Spinal Lesions: Clinical Experience in 125 Cases
81. Radiation Recall Dermatitis in Patients Treated with Sorafenib
82. Human papillomavirus, radiation dose and survival of patients with anal cancer
83. An Analysis of Outcomes and Primary Control in Locally Advanced Cervical Cancer Using a Hybrid Intracavitary/Interstitial Brachytherapy Device
84. Pretreatment Financial Toxicity Predicts Progression-Free Survival Following Concurrent Chemoradiotherapy for Locally Advanced Non-Small-Cell Lung Cancer
85. Predictors of prostate bed nodule on MRI in patients with rising PSA after radical prostatectomy.
86. Origin of Locoregional Recurrences After Definitive Intensity-modulated Radiation Therapy (IMRT) for Laryngeal Cancer Determined Based on Follow-up PET/CT Imaging
87. Neoadjuvant radiation therapy for the management of myoepithelial carcinoma of the upper extremity
88. Radiation therapy for patients with newly diagnosed metastatic head and neck squamous cell carcinoma
89. Biological impact of geometric uncertainties: what margin is needed for intra-hepatic tumors?
90. A new power law for determination of total 125I seed activity for ultrasound-guided prostate implants: clinical evaluations
91. Urinary morbidity with a modified peripheral loading technique of transperineal 125i prostate implantation
92. Point dose variations with time during traditional brachytherapy for cervical carcinoma
93. Salvage radiotherapy for prostate cancer recurrence after cryosurgical ablation
94. Trends in Physics Contributions to the 'Red Journal': A 30-year Journey and Comparison to Global Trends
95. Abstract CT005: FLT3 ligand (CDX-301) and stereotactic radiotherapy for advanced non-small cell lung cancer
96. Evaluating disparities in clinical trial accrual in an urban academic radiation oncology department.
97. NLR as a prognostic factor in solid tumors.
98. Adjuvant radiation “sandwiched” between 6 cycles of carboplatin and paclitaxel for FIGO stage III endometrioid adenocarcinoma.
99. Evaluating which plan quality metrics are appropriate for use in lung SBRT
100. Neoadjuvant radiation therapy for the management of myoepithelial carcinoma of the upper extremity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.